
BioXcel Therapeutics
Innovative Medicine Backed by the Power of AI

BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques. The company's proprietary AI platform is used to identify, re-innovate, and develop potential new therapies. BioXcel Therapeutics has a pipeline of product candidates in various stages of development, including BXCL501 for agitation in dementia, BXCL701 for cocaine use disorder, and BXCL801 for acute suicidal ideation and behavior in patients with major depressive disorder.
For Tasks:
Click tags to check more tools for each tasksFor Jobs:
Features
- Utilizes AI to identify, re-innovate, and develop potential new therapies
- Has a pipeline of product candidates in various stages of development
- Focuses on developing treatments for neuroscience and immuno-oncology
- Has a team of experienced scientists and researchers
- Is committed to developing innovative and effective treatments for patients
Advantages
- AI-driven drug development platform
- Accelerated drug development timelines
- Increased probability of success in clinical trials
- Focus on unmet medical needs
- Experienced team of scientists and researchers
Disadvantages
- Early-stage company with limited revenue
- Pipeline of product candidates is still in development
- AI-driven drug development is a relatively new approach
Frequently Asked Questions
-
Q:What is BioXcel Therapeutics?
A:BioXcel Therapeutics is a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques. -
Q:What is BioXcel Therapeutics' AI platform?
A:BioXcel Therapeutics' AI platform is a proprietary platform that is used to identify, re-innovate, and develop potential new therapies. -
Q:What is BioXcel Therapeutics' pipeline of product candidates?
A:BioXcel Therapeutics has a pipeline of product candidates in various stages of development, including BXCL501 for agitation in dementia, BXCL701 for cocaine use disorder, and BXCL801 for acute suicidal ideation and behavior in patients with major depressive disorder. -
Q:What is BioXcel Therapeutics' competitive advantage?
A:BioXcel Therapeutics' competitive advantage is its AI-driven drug development platform, which accelerates drug development timelines and increases the probability of success in clinical trials. -
Q:What are BioXcel Therapeutics' financial results?
A:BioXcel Therapeutics is an early-stage company with limited revenue. The company's financial results are available on its website.
Alternative AI tools for BioXcel Therapeutics
Similar sites

BioXcel Therapeutics
BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques. The company's proprietary AI platform is used to identify, re-innovate, and develop potential new therapies. BioXcel Therapeutics has a pipeline of product candidates in various stages of development, including BXCL501 for agitation in dementia, BXCL701 for cocaine use disorder, and BXCL801 for acute suicidal ideation and behavior in patients with major depressive disorder.

Institute for Protein Design
The Institute for Protein Design is a research institute at the University of Washington that uses computational design to create new proteins that solve modern challenges in medicine, technology, and sustainability. The institute's research focuses on developing new protein therapeutics, vaccines, drug delivery systems, biological devices, self-assembling nanomaterials, and bioactive peptides. The institute also has a strong commitment to responsible AI development and has developed a set of principles to guide its use of AI in research.

IXICO
IXICO is a precision analytics company specializing in intelligent insights in neuroscience. They offer a range of services for drug development analytics, imaging operations, and post-marketing consultancy. With a focus on technology and innovation, IXICO provides expertise in imaging biomarkers, radiological reads, volumetric MRI, PET & SPECT, and advanced MRI. Their TrialTracker platform and Assessa tool utilize innovation and AI for disease modeling and analysis. IXICO supports biopharmaceutical companies in CNS clinical research with cutting-edge neuroimaging techniques and AI technology.

QuantNexus
QuantNexus is an applied research collective that pioneers the future of molecular discovery through intelligent automation. Their mission is to empower the next generation of scientists by creating a human and AI partnership that advances biology significantly. The platform, NovoQuantNexus, fuses machine intelligence with human creativity to achieve breakthroughs in record time, outpacing conventional methods and pure-AI approaches. Researchers in pharma, biotech, and academia are leveraging this technology to accelerate discovery and redefine possibilities in life sciences.

XtalPi
XtalPi is a world-leading technology company driven by artificial intelligence (AI) and robotics to innovate in the fields of life sciences and new materials. Founded in 2015 at the Massachusetts Institute of Technology (MIT), the company is committed to realizing digital and intelligent innovation in the fields of life sciences and new materials. Based on cutting-edge technologies and capabilities such as quantum physics, artificial intelligence, cloud computing, and large-scale experimental robot clusters, the company provides innovative technologies, services, and products for global industries such as biomedicine, chemicals, new energy, and new materials.

Recursion
Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.

MeDA School
MeDA School is an educational platform dedicated to promoting and nurturing talents in the field of Medical Artificial Intelligence (AI). The platform aims to establish a solid foundation for intelligent and precision medical talent pools in Taiwan and globally. MeDA School facilitates interaction and communication among members of the intelligent medical ecosystem, fostering deep understanding and trust in the operation and tasks of medical AI. The platform offers a blend of virtual and physical courses, inviting domain experts to share cutting-edge knowledge and integrating interdisciplinary knowledge to be practically applied in various fields.

Linus Health
Linus Health is a next-generation digital cognitive assessment platform that enables earlier detection and intervention in brain health. It brings the power of AI to long-trusted cognitive tests, delivering rich insights and actionable clinical guidance. Linus Health's technology has been validated in over 20 published studies and is used by leading organizations to transform their approach to brain health.

Atomwise
Atomwise is an artificial intelligence (AI)-driven drug discovery company that uses machine learning to discover and develop new small molecule medicines. The company's AI engine combines the power of convolutional neural networks with massive chemical libraries to identify new drug candidates. Atomwise has a wholly owned pipeline of drug discovery programs and also partners with other pharmaceutical companies to co-develop drugs. The company's investors include prominent venture capital firms and pharmaceutical companies.

Atomwise
Atomwise is an AI-powered drug discovery company that uses machine learning to identify new small molecule medicines. The company's platform combines the power of convolutional neural networks with massive chemical libraries to discover new drug candidates. Atomwise has a portfolio of wholly owned and co-developed pipeline assets, and is backed by prominent investors.

Valo
Valo is a company that uses AI-driven technology to transform the discovery and development of life-changing medicines. They combine machine learning, tissue biology, and patient data to create a suite of powerful capabilities that bring the future of drug discovery and development to bear. Valo's team of software engineers, data scientists, biologists, medicinal chemists, and big-picture thinkers are dedicated to advancing the combined power of technology and patient data.

GenInnov
GenInnov is a generative innovation fund that provides a platform for investors seeking to be at the forefront of technological advancement. The fund invests in companies driving transformative change across multiple sectors and geographies, prioritizing material innovations with demonstrable profitability and global reach. GenInnov operates with a research-driven approach, focusing on investing in material innovations that are monetizable, profitable, and transformative, rather than incremental. The fund looks at various domains such as technology, robotics, consumer electronics, biotech, healthcare, mobility, and clean tech, aiming to amplify human creativity through machine intelligence.

OpenAI
OpenAI is an artificial intelligence research laboratory consisting of the for-profit OpenAI LP and the non-profit OpenAI Inc. The organization focuses on creating and promoting friendly AI for the benefit of humanity. OpenAI conducts research in the field of AI and aims to ensure that artificial general intelligence benefits all of humanity. The organization is known for its research in natural language processing, reinforcement learning, and other areas of AI. OpenAI also develops and releases AI models and tools to advance the field of artificial intelligence.

Amazon Science
Amazon Science is a research and development organization within Amazon that focuses on developing new technologies and products in the fields of artificial intelligence, machine learning, and computer science. The organization is home to a team of world-renowned scientists and engineers who are working on a wide range of projects, including developing new algorithms for machine learning, building new computer vision systems, and creating new natural language processing tools. Amazon Science is also responsible for developing new products and services that use these technologies, such as the Amazon Echo and the Amazon Fire TV.

HealthITAnalytics
HealthITAnalytics is a leading source of news, insights, and analysis on the use of information technology in healthcare. The website covers a wide range of topics, including artificial intelligence, machine learning, data analytics, and population health management. HealthITAnalytics also provides resources for healthcare professionals, such as white papers, webinars, and podcasts.

Neurotechnology
Neurotechnology is an AI-driven company specializing in biometric technologies, artificial intelligence, and computer vision. With over 35 years of research and development experience, the company offers a wide range of products and solutions for biometric identification, surveillance, and authentication. Neurotechnology's innovative AI applications are used in various industries, including security, law enforcement, and healthcare, to enhance efficiency and accuracy in identity verification and data analysis.
For similar tasks

BioXcel Therapeutics
BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques. The company's proprietary AI platform is used to identify, re-innovate, and develop potential new therapies. BioXcel Therapeutics has a pipeline of product candidates in various stages of development, including BXCL501 for agitation in dementia, BXCL701 for cocaine use disorder, and BXCL801 for acute suicidal ideation and behavior in patients with major depressive disorder.

Insitro
Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

Recursion
Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.

Atomwise
Atomwise is an AI-powered drug discovery company that uses machine learning to identify new small molecule medicines. The company's platform combines the power of convolutional neural networks with massive chemical libraries to discover new drug candidates. Atomwise has a portfolio of wholly owned and co-developed pipeline assets, and is backed by prominent investors.
For similar jobs

DrugCard
DrugCard is an AI-enabled Data Intelligence platform designed to streamline drug safety routines. It offers solutions for pharmacovigilance by providing services such as local literature screening, regulatory intelligence, adverse event database, and eCTDlight services. The platform supports multiple languages, covers medical journals from over 100 countries, and saves up to 60% of time compared to manual approaches. DrugCard aims to enhance pharmacovigilance processes by leveraging AI, automation, and traceability.

Beacon Biosignals
Beacon Biosignals provides an EEG neurobiomarker platform that is designed to accelerate clinical trials and enable new treatments for patients with neurological and psychiatric diseases. Their platform is powered by machine learning and a world-class clinico-EEG database, which allows them to analyze existing EEG data for insights into mechanisms, PK/PD, and patient stratification. This information can be used to guide further development efforts, optimize clinical trials, and enhance understanding of treatment efficacy.

Insitro
Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

AiCure
AiCure provides a patient-centric eClinical trial management platform that enhances drug development through improved medication adherence rates, more powerful analysis and prediction of treatment response using digital biomarkers, and reduced clinical tech burden. AiCure's solutions support traditional, decentralized, or hybrid trials and offer flexibility to meet the needs of various research designs.

BioXcel Therapeutics
BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques. The company's proprietary AI platform is used to identify, re-innovate, and develop potential new therapies. BioXcel Therapeutics has a pipeline of product candidates in various stages of development, including BXCL501 for agitation in dementia, BXCL701 for cocaine use disorder, and BXCL801 for acute suicidal ideation and behavior in patients with major depressive disorder.

Intelligencia AI
Intelligencia AI is a leading provider of AI-powered solutions for the pharmaceutical industry. Our suite of solutions helps de-risk and enhance clinical development and decision-making. We use a combination of data, AI, and machine learning to provide insights into the probability of success for drugs across multiple therapeutic areas. Our solutions are used by many of the top global pharmaceutical companies to improve their R&D productivity and make more informed decisions.

Rationale
Rationale is a cutting-edge decision-making tool powered by advanced AI technology, including the latest GPT model and in-context learning capabilities. It leverages artificial intelligence to provide users with valuable insights and recommendations for making informed decisions across various domains.

Mnemonic AI
Mnemonic AI is an advanced Customer Intelligence tool that offers AI Personas and Digital Twin of the Customer. It helps organizations improve their understanding of individuals by creating data-driven buyer personas and virtual customers. The tool analyzes OCEAN Big Five Personality Traits and Schwartz Universal Values to tailor messages and marketing strategies. Mnemonic AI automates the process of creating personas and updating customer data, providing deep insights for informed decision-making.

functime
functime is a time-series machine learning tool designed to perform forecasting at scale. It provides functions for scoring, ranking, and plotting thousands of forecasts simultaneously. With a focus on guiding users through their first end-to-end forecasting pipeline, functime serves as an AI copilot to analyze trends, seasonality, and causal factors in forecasts. The tool offers a comprehensive API reference and documentation, making it a valuable resource for both beginners and experienced analysts.

Kolank
Kolank is an AI platform offering a unified API with agent interoperability, automatic model selection, and cost optimization. It enables AI agents to communicate and collaborate efficiently, providing access to a wide range of AI models for text, image, and video processing. With features like load balancing, fallbacks, and performance metrics, Kolank simplifies AI model integration and usage, making it a comprehensive solution for various AI tasks.

Promptmakr
Promptmakr is a platform designed for buying and selling AI prompts. It serves as a marketplace where users can find and offer AI prompts for various purposes. The platform aims to connect individuals and businesses looking for AI prompts with those who create and sell them. With a user-friendly interface, Promptmakr simplifies the process of discovering, purchasing, and selling AI prompts, making it a convenient solution for both buyers and sellers in the AI industry.

StockGPT
StockGPT is an AI-powered financial research assistant that provides knowledge of earnings releases, financial reports, and fundamental information for S&P 500 and Nasdaq companies. It offers features like AI-powered search, customizable filters, up-to-date data, and industry research to help users analyze companies and markets more efficiently.

XenonStack
XenonStack is an AI application that offers a comprehensive suite of tools and services for building and managing Agentic Systems. The platform provides solutions for data management, analytics, AI transformation, and decision-making processes. With features like AI-enabled catalogs, industrial automation, and agent orchestration, XenonStack aims to empower enterprises to reimagine their business workflows and drive efficiency and agility through intelligent AI agents.

Unlearn.ai
Unlearn.ai is an AI-driven platform that specializes in streamlining clinical trials through the use of AI-generated digital twins of patients. By leveraging digital twin technology and disease-specific ML models, Unlearn.ai enables researchers to design and run more efficient and impactful clinical trials across various therapeutic areas. The platform offers solutions to accelerate trial timelines, facilitate faster decision-making, and optimize trial design, ultimately enhancing trial efficiency, insights, and impact.

Discuro
Discuro is an all-in-one platform designed for developers to easily build, test, and consume complex AI workflows. It integrates with GPT-3, DALLE-2, and older OpenAI models, allowing users to chain prompts together in powerful ways. With Discuro, users can define their workflows in an easy-to-use UI and execute them with a single API call. The platform enables users to build and test complex self-transforming AI workflows and data sets, monitor AI usage, and generate completions efficiently.

Google Colab Copilot
Google Colab Copilot is an AI tool that integrates the GitHub Copilot functionality into Google Colab, allowing users to easily generate code suggestions and improve their coding workflow. By following a simple setup guide, users can start using the tool to enhance their coding experience and boost productivity. With features like code generation, auto-completion, and real-time suggestions, Google Colab Copilot is a valuable tool for developers looking to streamline their coding process.

Zomory
Zomory is an AI-powered knowledge search tool that allows users to search their Notion workspace with lightning-fast speed. It offers natural language understanding, Slack integration, conversational interface, page search, and enterprise security. Zomory is designed to provide users with instant access to the information they need, even if they are unsure of the exact keywords. It aims to revolutionize the way users search for knowledge within their workspace by combining AI technology with user-friendly features.

Lobe
Lobe is a free and easy-to-use machine learning tool for Mac and PC that helps users train machine learning models and deploy them to any platform. It offers a range of features such as creating image-based datasets, managing and comparing prompts, automating workflows, and collaborating outside of code. Lobe provides a user-friendly interface for individuals and teams to leverage AI technology without extensive coding knowledge.

Aitodata
Aitodata.com is an AI tool designed to provide advanced data analysis solutions. The platform offers a wide range of features to help users analyze and interpret data more effectively. With a user-friendly interface, Aitodata.com aims to simplify the process of data analysis for individuals and businesses alike. The tool is known for its accuracy, efficiency, and reliability in handling complex data sets.

Sushidata Analytics
Sushidata Analytics is an AI-powered platform that helps companies gain a competitive edge by unifying and automating critical competitive and marketing operations data. It offers fully automated analysis of data, identifies key trends and advocates, and provides actionable insights to marketing teams. The platform assists in monitoring competition, turning customer feedback into actionable strategies, and enhancing customer experience. Sushidata prioritizes data security and offers integrations with various tools for seamless data collection and analysis.

GPT-4 Consulting
GPT-4 Consulting is an AI tool that provides business advice and software consultation services. Users can book consultations to get advice on leveraging AI for their businesses. The tool uses advanced AI technology to generate personalized advice based on the user's input.

Weaviate
Weaviate is an AI-native database that developers love. It offers a feature-rich vector database trusted by AI innovators, empowering AI-native builders to create AI-powered search, retrieval augmented generation, and agentic AI applications. Weaviate simplifies the process of building production-ready AI applications by providing seamless model integration, pre-built database agents, and language-agnostic SDKs for easy development. With billion-scale architecture and enterprise-ready deployment options, Weaviate enables developers to scale seamlessly, deploy anywhere, and meet enterprise requirements. The platform is designed to help AI builders write less custom code, optimize costs, and build AI-native apps faster.

Microsoft Azure
Microsoft Azure is a cloud computing service that offers a wide range of products and solutions for businesses and developers. It provides tools for AI, machine learning, databases, analytics, compute, containers, hybrid cloud, and more. Azure enables users to build, deploy, and scale AI-powered applications and agents faster, with a focus on data security and flexibility. The platform offers a pay-as-you-go model and a free trial period of up to 30 days, with no upfront commitment required. Azure aims to empower businesses to innovate and modernize their applications and infrastructure in a secure and scalable environment.

Questflow
Questflow is an AI agent economy platform that enables users to automate tasks, turn user feedback into action, and build AI agent teams for various workflows. It offers a developer platform to design and deploy AI swarms, empowering teams and innovators worldwide. Questflow aims to create a multi-agent economy on-chain, connecting AI agents to all apps and allowing users to customize AI agent-powered applications. With features like autonomous task completion, on-chain incentives for builders, and tokenization of AI agents, Questflow provides a composable solution for orchestrating AI agents to work together seamlessly.